| Literature DB >> 30183247 |
Yaojia Li1, Zhiguo Gao1, Fanghui Chen1, Chaoqun You1, Hongshuai Wu1, Kai Sun1, Peijing An1, Kaiwu Cheng1, Chen Sun1, Xiaoli Zhu2, Baiwang Sun1.
Abstract
Herein, a biocompatible 2D metal-organic frameworks (Cu-TCPP(Fe)) based on TCPP(M) (TCPP = tetrakis (4-carboxyphenyl) porphyrin, M = Fe) and copper ion were synthesized as a novel drug carrier. Sequentially, the cisplatin was loaded on the merge of carboxyl-rich Cu-TCPP(Fe) through forming favorable carboxyl-drug interactions. The prepared Pt/Cu-TCPP(Fe) showed highly enhanced cytotoxicity than that of free cisplatin in human pulmonary carcinoma A549 cells, whereas inverse inhibitory effects were observed in human normal BEAS-2B cells. Further, the mechanism of action about the desirable results was also elaborated. Our study highlighted the potential synergies between the nanocarrier and the anticancer drugs.Entities:
Keywords: Fenton reaction; cisplatin; metal−organic frameworks; nanocarrier; reactive oxygen species
Year: 2018 PMID: 30183247 DOI: 10.1021/acsami.8b12800
Source DB: PubMed Journal: ACS Appl Mater Interfaces ISSN: 1944-8244 Impact factor: 9.229